Nature Reviews Urology

Article	Citations
CDH12-expressing cell population predicts patient response to therapy	164
Krause corpuscles act as genital vibration detectors	152
Exploratory results from the CheckMate 214 trial	124
Immune infiltration associated with outcomes	97
Semen quality recovery following COVID-19	84
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	73
Texture analysis for patient selection	66
Single-cell and spatial sequencing of kidney cancer	62
Human-relevant urothelial model provides insight into infection strategies and host response	59
Sexual recovery interventions following prostate cancer treatment	59
RAL-P in infants: expert tips for success	58
Time for women-centred gynaecology	58
Urine microbiota differ in bladder cancer	56
PARP inhibitors plus enzalutamide to treat mCRPC	56
Considering urology in a planetary context	54
Advancing the state of the art in congenital obstructive uropathy	52
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	52
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery	51
Preclinical models of bladder cancer: BBN and beyond	48
High-dose chemotherapy for relapsed testicular germ cell tumours	46
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	45
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity	45
A clinical guide to rare male sexual disorders	45
FOXA2–KIT-driven lineage plasticity in NEPC	44
Proteomic-based analysis of testicular interstitial fluid	44

Prevalence of gender dysphoria in Japan	43
Microfluidic sperm selection	43
A new text message-based platform for self-management of patients with IC/BPS	40
Madrid plays host to a celebration of urology	39
Promise without practice — charting the path forward for bladder cancer biomarkers	39
What happens in Vegas … shapes the future of urology	39
Ibrexafungerp to treat acute vulvovaginal candidiasis	37
Galectins as potential therapeutic targets in STIs in the female genital tract	36
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	36
Metaverse in surgery — origins and future potential	34
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	34
Overcoming antibiotic resistance in complicated UTI	34
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	34
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	33
Evolution of the World Health Organization semen analysis manual: where are we?	32
Reducing the stigma of academic mental health can save lives	32
Resolving the puzzle of same-sex sexual interactions	31
COVID can’t kill CopMich collaboration	31
Pembrolizumab + axitinib beyond first-line therapy for mRCC	31
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	31
A non-invasive assay for UTUC diagnosis	31
Efficacy of the Revi system in treating urgency urinary incontinence	29
Personalized 3D models for prostate cancer surgery	29
Vaccination to prevent untreatable gonorrhoea	29
PEACEing together prostate cancer therapy	29
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	29
The mechanism of action of neuromodulation in the treatment of overactive bladder	29
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	28
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	28
Measuring and improving the cradle-to-grave environmental performance of urological procedures	28
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	27
Effect of high glucose on E. coli	26
Is it time to rethink the current patient-reported outcome measures?	25
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	25
Sexual orientation, gender identity and COVID: a complicated picture	24
Cribriform morphology affects mpMRI imaging	23
Secondary kidney stones — remove or leave?	23
The magic of MagSToNE	23
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	23
Successful mentorship for women in urology — a new era	22
Women in urology: the past	22
A clinical overview of people living with HIV and genitourinary cancer care	22
AUA returns to its former glory in Chicago	22
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	22
Promising efficacy of UTI vaccines as an alternative to antibiotics	21
Prostate cancer in transgender women — challenges in research and clinical care	21
Microultrasonography-guided prostate cancer biopsy	21
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	20
Videourodynamics — role, benefits and optimal practice	20
The placebo and nocebo effects in functional urology	19

Robots learning to imitate surgeons — challenges and possibilities	19
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	18
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	17
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	16
Metabolic response to immunotherapy in prostate cancer	16
Androgen receptor pathway inhibitor combination in prostate cancer	16
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	15
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	15
Management and cost of stent encrustation in pregnancy	15
The future of patient-derived xenografts in prostate cancer research	14
Pride, not prejudice	14
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	14
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	14
The evolving treatment landscape of metastatic urothelial cancer	13
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	13
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	12
Turning up the heat: CTLA4 blockade in urothelial cancer	12
The unclear role of PET–CT in localized radiorecurrent prostate cancer	11
Immune-based therapies in penile cancer	11
The value of women urologists — individual and institutional imperatives to address salary equity	11
The prognostic role of stroma in UTUC	11
Uncovering a link between COVID-19 and renal cell carcinoma	10
The shifting treatment paradigm of metastatic renal cell carcinoma	10
We all get erections — de-gendering sexual arousal dysfunction in the ICD	10
Turning back time in the testes	10
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	10
Hallmark discoveries in the biology of Wilms tumour	10
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	10
Effects of COVID-19 vaccine on semen parameters	9
BAUSing back in Birmingham	9
Improved phenotypic classification of male infertility to promote discovery of genetic causes	9
Understanding iGCA	9
Pelvic-fascia-sparing techniques and outcomes with RARP	9
Current and future pharmacotherapy for female sexual dysfunction	9
CMA mediates resistance to androgen inhibitors in prostate cancer	9
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	9
Tuft cells in prostate cancer	8
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	8
Men hold the balance of power	8
Metabolism, mitochondria and metastasis in kidney cancer	8
Male infertility and somatic health — insights into lipid damage as a mechanistic link	8
Mellow yellow: BilR reduces bilirubin to urobilinogen	8
Power up to investigate PrEP	8
Diagnosis of ccRCC	8
Microbiota manipulation to prevent oxalate kidney stone formation	8
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	8
Patient selection is key in IMbassador250	8
Sperm activity affected by endometriosis	7
Mechanisms of the Supra-T paradox	7
MRI diagnosis and radical prostatectomy outcomes	7
Semen parameters across testicular cancer stages	7
Genetic ancestry and racial differences in prostate tumours	7
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	7
Spatiotemporal trends in human semen quality	7
The ins and outs of penile erection	6
Toilet-based continuous health monitoring using urine	6
Chlorination by-products in drinking water — association with bladder cancer risk	6
Syphilis on the rise — a need for alternative therapies and vaccines	6
Stepping up to prevent bacterial vaginosis recurrence	6
Advances in sliding clip renorrhaphy for partial nephrectomy	6
Pronouns in English: a user’s guide	6
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	5
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	5
The effects of diet on prostate cancer outcomes	5
ADT intensification to treat biochemically recurrent prostate cancer	5
Genetic and biological drivers of prostate cancer disparities in Black men	5
Artificial intelligence in the management of prostate cancer	5
Testosterone replacement therapy and spermatogenesis in reproductive age men	5
Visual clues — dermatological manifestations of sexually transmitted infections in men	5
Pregnancy and parental leave in medicine and academia — a focus on urology	5
Feasibility and potential of an MRI-based prostate cancer screening	5
Prescribing clinician specialty influences adherence to PrEP	5
Clinical trial design for non-muscle-invasive bladder cancer	5
Prostate luminal progenitor cells: from mouse to human, from health to disease	5
Particulate matter leaves a bitter taste in testes	5
Influence of substance use on male reproductive health and offspring outcomes	5
The future of pelvic lymph node dissection for urological malignancies	5
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning	5
Urology on a changing planet: links between climate change and urological disease	5
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	5

New insights into APOBEC-mediated mutagenesis in prostate cancer	4
Being a non-native English speaker in science and medicine	4
Reply to ‘Management of very young fetuses with LUTO’	4
Gut microbiome’s effect on immunotherapy response	4
A vagina on a chip to model microbiome–host interactions	4
The effect of red blood cell disorders on male fertility and reproductive health	4
Advancing perioperative care in MIBC: insights from NIAGARA	4
An app for optimizing UTI screening	4
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects	4
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma	4
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment	4
Iatrogenic upper urinary tract injuries during ureteroscopy for urolithiasis: a comprehensive review on incidence, mechanisms and preventative strategies	4
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications	4
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury	4
Bone marrow microenvironment in prostate cancer	4
Improving care for transgender and non-binary individuals	4
The prostatic middle lobe: clinical significance, presentation and management	4
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer	4
Sexual transfer of bacteria for forensic use	4
Landmarks in the evolution of prostate biopsy	4
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research	4
Urinary microbiota associated with OAB symptoms	3
Prostate cancer epigenetics — from pathophysiology to clinical application	3
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer	3
Bladder EpiCheck for NMIBC	3
Knockout of extended pelvic lymph node dissection during radical cystectomy	3
Generative AI in scientific publishing: disruptive or destructive?	3
The potential role of the microbiota in prostate cancer pathogenesis and treatment	3
Perspectives in primary hyperoxaluria — historical, current and future clinical interventions	3
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy	3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?	3
Sex differences in bladder cancer: emerging data and call to action	3
Non-human primates as a translational model for the study of male reproductive health	3
Human sperm RNA in male infertility	3
Perspectives on chemsex	3
From foes to friends: rethinking the role of lymph nodes in prostate cancer	3
Health-related quality of life after curative treatment for muscle-invasive bladder cancer	3
Immunoliposome targeting IL-30	3
Metabolic alterations drive enzalutamide resistance	3
Clinical hypnosis improves LUTS	3
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence	3
Metastasis development in non-muscle-invasive bladder cancer	3
Mapping the human prostate at the cellular level	3
Proteomic characterization of bladder cancer	3
A new surgical procedure to treat BPH	3
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC	3
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care	3
20 years of ‘spilling the tea’ in urology	2
Targeting TGCT	2
NMIBC risk factors in patients treated with BCG	2
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy	2
Focusing on male infertility	2
An epigenomic atlas for RCC	2
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer	2
AI for drug discovery	2
Patient-reported toxic effects of hypofractionated versus conventional RT	2
UPEC-mediated alteration of host mitochondrial function — a survival strategy	2
Intestinal microbiota drive CRPC	2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer	2
Accessing information in the AI age	2
Microplastics in the penis	2
Molecular and therapeutic landscape of non-clear cell renal carcinoma	2
Simulating nature in sperm selection for assisted reproduction	2
Intravesical ICIs to reduce toxicity in NMIBC	2
The dynamic roles of the bladder tumour microenvironment	2
PROTACs for prostate cancer	2
The burden of kidney transplant evaluation — an older adults’ perspective	2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration	2
Adjuvant personalized cancer vaccine: is this the end of metastatic kidney cancer	2
Abortion is a urology workforce issue	2
Robotic kidney transplantation	2
Islatravir implant as HIV-1 pre-exposure treatment	2
Control of oncogenic signalling in ccRCC	2
Utility of PSA screening in transgender women receiving oestrogens	2
Experimental in vitro, ex vivo and in vivo models in prostate cancer research	2
The International Penile Prosthesis Implant Consensus Forum: clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant	2
Artificial intelligence in academic writing: a paradigm-shifting technological advance	2
WGC in patients with localized prostate cancer	2
Metabolic flexibility in ccRCC	2
Effects of the environment on the evolution of the vertebrate urinary tract	2
AI in prostate MRI: enhancing accuracy and reducing overdiagnosis	1
Interactions between androgen and IGF1 axes in prostate tumorigenesis	1
Quality of life in sexual minorities following prostate cancer treatment	1
What is fuelling the monkeypox outbreak?	1
Immunoproteasome inhibition in CRPC	1
First-morning urine samples to study the urobiome	1
Opening up about cancer and mental health	1
State of the art — biomarkers in advanced prostate cancer	1
Paternal microbiome perturbations affect offspring outcomes	1
ML-guided decision for patient discharge location	1
The relationship between Black men with prostate cancer and their health-care providers	1
Reply to ‘The disruption of circadian rhythm as a potential mechanism of nocturia-like symptoms — a paediatric urology perspective’	1
Urine biomarkers in bladder cancer — current status and future perspectives	1
Prostate zones and cancer: lost in transition?	1
Intralesional heterogeneity on PSMA PET–CT predicts mCRPC outcomes	1